NasdaqGM:OCULPharmaceuticals
Does Broad Russell Value Index Inclusion Reshape the Bull Case for Ocular Therapeutix (OCUL)?
On 27 June 2026, Ocular Therapeutix, Inc. (NasdaqGM: OCUL) was added to multiple Russell value benchmarks, including the Russell 3000 Value, 2000 Value, 2500 Value, 3000E Value, and Small Cap Comp Value indices.
This broad Russell value index inclusion can increase visibility among institutional investors and passive funds that track these benchmarks, potentially reshaping how the market assesses Ocular Therapeutix's risk and exposure profile.
We will now examine how Ocular Therapeutix's...